- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
-
- 长期趋势：
已有124家主力机构披露2024-12-31报告期持股数据，持仓量总计2.80亿股，占流通A股48.47%
- 波段诊断：
-
技术面诊股
诊断结果：3.5技术面打败了67%的股票
技术面评分前10的股票
近期的平均成本为15.84元。
平均成本
近期的平均成本为15.84元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"15.84","date":1751531322,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑赢大盘，接近行业平均水平。
[{"date":"2025.07.04","stock":"-0.19","trade":"-0.36","ind":"0.32"},{"date":"2025.07.03","stock":"4.55","trade":"1.72","ind":"0.18"},{"date":"2025.07.02","stock":"-1.37","trade":"-0.30","ind":"-0.09"},{"date":"2025.07.01","stock":"3.99","trade":"1.61","ind":"0.39"},{"date":"2025.06.30","stock":"-0.67","trade":"0.30","ind":"0.59"},{"date":"2025.06.27","stock":"2.83","trade":"0.38","ind":"-0.70"},{"date":"2025.06.26","stock":"-2.10","trade":"-0.51","ind":"-0.22"},{"date":"2025.06.25","stock":"-1.92","trade":"0.24","ind":"1.03"},{"date":"2025.06.24","stock":"-0.46","trade":"1.40","ind":"1.15"},{"date":"2025.06.23","stock":"2.78","trade":"0.71","ind":"0.65"},{"date":"2025.06.20","stock":"-0.47","trade":"-0.05","ind":"-0.07"},{"date":"2025.06.19","stock":"-4.52","trade":"-1.61","ind":"-0.79"},{"date":"2025.06.18","stock":"-1.46","trade":"-1.39","ind":"0.04"},{"date":"2025.06.17","stock":"-1.81","trade":"-0.79","ind":"-0.04"},{"date":"2025.06.16","stock":"-0.68","trade":"-0.34","ind":"0.35"},{"date":"2025.06.13","stock":"-6.44","trade":"-2.44","ind":"-0.75"},{"date":"2025.06.12","stock":"5.64","trade":"0.26","ind":"0.01"},{"date":"2025.06.11","stock":"9.97","trade":"0.22","ind":"0.52"},{"date":"2025.06.10","stock":"1.85","trade":"0.01","ind":"-0.44"},{"date":"2025.06.09","stock":"5.73","trade":"2.07","ind":"0.43"},{"date":"2025.06.06","stock":"-2.48","trade":"0.04","ind":"0.04"}]
康缘药业,上证指数,中药指数
压力支撑
该股压力位为15.84元，支撑位为15.60元。
[{"text":"\u538b\u529b\u4f4d","value":"15.84","date":1751558400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"15.60","date":1751558400,"color":"0x0b52a1"}]
多空趋势
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.9资金面打败了60%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金总体无进出。
更新时间：07月04日 20:30
| 机构今日流向(万元) | -442.59 | 机构5日流向(万元) | -621.39 |
| 机构10日流向(万元) | -3117.34 | 机构20日流向(万元) | -17830.65 |
机构持仓
2024-12-31 与 2024-06-30 相比，主力机构持仓量减少3897.81万股，其中基金净减仓22家，主力净减仓111家，请投资者中长期谨慎为宜。
截止2024-12-31，共124家主力机构（基金116家，一般法人8家），持仓量总计28041.5万股，占流通A股48.47%
其中，基金持仓与2024-06-30相比：
增仓：21家 ，增持 360.67万股
减仓：43家 ，减持 1404.43万股
新出现在主力名单中：46家 ，持有1174.09万股
从主力名单中消失：157家 ，原持有3267.43万股
其中，基金持仓与2024-06-30相比：
增仓：21家 ，增持 360.67万股
减仓：43家 ，减持 1404.43万股
新出现在主力名单中：46家 ，持有1174.09万股
从主力名单中消失：157家 ，原持有3267.43万股
消息面诊股
诊断结果：5.5消息面打败了52%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 康缘药业 1 类化学新药获批临床，中药企业创新药布
2025-07-04 - 多肽新药，KYS2301凝胶IND:针对特应性皮炎
2025-07-04 - 康缘药业：7月3日获融资买入6696.49万元，占
2025-07-04 - 低估璞玉资产，三靶大药打开空间
2025-07-03 - 康缘药业：KYS2301凝胶获临床试验批准
2025-07-03 - 康缘药业：7月2日获融资买入1610.63万元
2025-07-03 - 康缘药业：7月1日获融资买入3911.94万元，占
2025-07-02 - 康缘药业：龙七胶囊已进入CDE技术审评阶段，公司正
2025-07-01 - 【瞩目】康缘药业1类新药来袭！瞄准300亿蓝海
2025-07-01 - 未按要求调整药品价格，两款短缺药被暂停采购资格
2025-07-01
消息列表
| 一般消息 | 高管变动 | 因个人原因 | 2025-06-20 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-25 |
| 一般消息 | 高管变动 | 因个人原因 | 2025-04-24 |
| 一般消息 | 股东大会 | 年度股东大会 | 2025-04-03 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-04-03 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-03 |
| 一般消息 | 重大事项 | 关联交易 | 2024-11-08 |
| 一般消息 | 重大事项 | 关联交易 | 2024-08-13 |
| 一般消息 | 分红转增 | 不分配不转增 | 2024-07-27 |
| 一般消息 | 高管变动 | 因个人原因 | 2024-07-15 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 0条 | 0条 | 0条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：7.2行业面打败了90%的股票
中药行业最新资金流向
近10日来该行业走势明显向上，跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势明显向上，跑赢大盘。
[{"date":"2025.07.04","price":"0.32","value":"-0.36"},{"date":"2025.07.03","price":"0.18","value":"1.72"},{"date":"2025.07.02","price":"-0.09","value":"-0.30"},{"date":"2025.07.01","price":"0.39","value":"1.61"},{"date":"2025.06.30","price":"0.59","value":"0.30"},{"date":"2025.06.27","price":"-0.70","value":"0.38"},{"date":"2025.06.26","price":"-0.22","value":"-0.51"},{"date":"2025.06.25","price":"1.03","value":"0.24"},{"date":"2025.06.24","price":"1.15","value":"1.40"},{"date":"2025.06.23","price":"0.65","value":"0.71"},{"date":"2025.06.20","price":"-0.07","value":"-0.05"},{"date":"2025.06.19","price":"-0.79","value":"-1.61"},{"date":"2025.06.18","price":"0.04","value":"-1.39"},{"date":"2025.06.17","price":"-0.04","value":"-0.79"},{"date":"2025.06.16","price":"0.35","value":"-0.34"},{"date":"2025.06.13","price":"-0.75","value":"-2.44"},{"date":"2025.06.12","price":"0.01","value":"0.26"},{"date":"2025.06.11","price":"0.52","value":"0.22"},{"date":"2025.06.10","price":"-0.44","value":"0.01"},{"date":"2025.06.09","price":"0.43","value":"2.07"},{"date":"2025.06.06","price":"0.04","value":"0.04"}]
上证指数,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 方盛制药 | 154.43% | 5.52% | 5.7分 |
| 2 | 贵州百灵 | 39.37% | 10.96% | 4.8分 |
| 3 | 恩威医药 | 21.45% | 5.65% | 4.5分 |
| 4 | 启迪药业 | 18.13% | 11.81% | 4.9分 |
| 5 | 康惠制药 | 16.79% | 12.52% | 4.7分 |
| 6 | 众生药业 | 15.95% | 8.10% | 5.1分 |
| 8 | 佐力药业 | 11.32% | 12.64% | 5.7分 |
| 10 | 九芝堂 | 5.79% | 14.41% | 5.6分 |
| 12 | 汉森制药 | 4.85% | 4.34% | 4.7分 |
| 14 | 红日药业 | 3.93% | 7.59% | 4.9分 |
| 16 | 以岭药业 | 3.66% | 6.99% | 5.5分 |
| 18 | 新天药业 | 3.20% | 4.65% | 4.6分 |
| 20 | 莱茵生物 | 2.65% | 4.50% | 5.2分 |
| 22 | 益佰制药 | 2.28% | 4.95% | 5.1分 |
| 24 | 粤万年青 | 1.73% | 5.19% | 4.7分 |
| 26 | 羚锐制药 | 1.51% | 3.66% | 5.2分 |
| 28 | ST香雪 | 1.09% | -1.30% | 4.2分 |
| 30 | 益盛药业 | 0.50% | 3.37% | 4.8分 |
| 32 | 葵花药业 | 0.45% | 1.02% | 3.8分 |
| 34 | 新光药业 | 0.20% | 3.56% | 4.7分 |
| 36 | 仁和药业 | 0.00% | 1.48% | 4.6分 |
| 38 | 白云山 | -0.30% | 0.65% | 4.9分 |
| 40 | 天目药业 | -0.95% | -0.29% | 5.4分 |
| 42 | 嘉应制药 | -1.09% | 3.94% | 4.9分 |
| 44 | 云南白药 | -1.43% | -0.16% | 5.5分 |
| 46 | 片仔癀 | -2.19% | -1.06% | 4.5分 |
| 48 | 天士力 | -2.27% | 1.59% | 5.1分 |
| 50 | 陇神戎发 | -2.73% | 3.74% | 5.1分 |
| 52 | 桂林三金 | -3.70% | 1.32% | 5.5分 |
| 54 | 健民集团 | -4.10% | -0.48% | 4.5分 |
| 56 | 寿仙谷 | -4.62% | -0.19% | 3.7分 |
| 58 | ST葫芦娃 | -5.32% | 0.11% | 4.5分 |
| 60 | 东阿阿胶 | -6.86% | -2.66% | 4.6分 |
| 62 | 昆药集团 | -7.37% | 0.00% | 4.1分 |
| 64 | - | -21.92% | -3.26% | 分 |
| 66 | 广誉远 | - | 0.00% | 5.8分 |
| 68 | 盘龙药业 | - | 3.78% | 4.9分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-03-31 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 40/112 ， 11/112。
[{"date":"2025-03-31","value":"1.83","vol":"2.23"},{"date":"2024-12-31","value":"8.07","vol":"5.32"},{"date":"2024-09-30","value":"6.91","vol":"2.95"},{"date":"2024-06-30","value":"5.13","vol":"1.60"},{"date":"2024-03-31","value":"2.81","vol":"1.67"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
1.83 | 8.07 | 6.91 | 5.13 | 2.81 |
| 行业(%) | 2.23 | 5.32 | 2.95 | 1.60 | 1.67 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"74.18","vol":"53.01"},{"date":"2024-12-31","value":"73.22","vol":"52.47"},{"date":"2024-09-30","value":"74.20","vol":"52.77"},{"date":"2024-06-30","value":"74.55","vol":"53.17"},{"date":"2024-03-31","value":"74.61","vol":"53.62"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
74.18 | 73.22 | 74.20 | 74.55 | 74.61 |
| 行业(%) | 53.01 | 52.47 | 52.77 | 53.17 | 53.62 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 62/112 ， 49/112。
[{"date":"2025-03-31","value":"-35.38","vol":"-5.22"},{"date":"2024-12-31","value":"-19.86","vol":"-6.80"},{"date":"2024-09-30","value":"-11.06","vol":"-4.36"},{"date":"2024-06-30","value":"-11.49","vol":"-4.12"},{"date":"2024-03-31","value":"0.48","vol":"-2.27"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-35.38 | -19.86 | -11.06 | -11.49 | 0.48 |
| 行业(%) | -5.22 | -6.80 | -4.36 | -4.12 | -2.27 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"-38.37","vol":"-35.55"},{"date":"2024-12-31","value":"-15.58","vol":"-101.25"},{"date":"2024-09-30","value":"2.18","vol":"-6.00"},{"date":"2024-06-30","value":"-3.73","vol":"-15.66"},{"date":"2024-03-31","value":"4.67","vol":"-9.41"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-38.37 | -15.58 | 2.18 | -3.73 | 4.67 |
| 行业(%) | -35.55 | -101.25 | -6.00 | -15.66 | -9.41 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 29/112 ， 40/112。
[{"date":"2025-03-31","value":"0.13","vol":"0.12"},{"date":"2024-12-31","value":"0.56","vol":"0.49"},{"date":"2024-09-30","value":"0.44","vol":"0.37"},{"date":"2024-06-30","value":"0.32","vol":"0.26"},{"date":"2024-03-31","value":"0.19","vol":"0.13"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.13 | 0.56 | 0.44 | 0.32 | 0.19 |
| 行业(次) | 0.12 | 0.49 | 0.37 | 0.26 | 0.13 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"0.43","vol":"0.62"},{"date":"2024-12-31","value":"2.34","vol":"2.41"},{"date":"2024-09-30","value":"1.79","vol":"1.80"},{"date":"2024-06-30","value":"1.35","vol":"1.24"},{"date":"2024-03-31","value":"0.93","vol":"0.66"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.43 | 2.34 | 1.79 | 1.35 | 0.93 |
| 行业(次) | 0.62 | 2.41 | 1.80 | 1.24 | 0.66 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-03-31","value":"8.77","vol":"2.34"},{"date":"2024-12-31","value":"12.05","vol":"15.76"},{"date":"2024-09-30","value":"25.51","vol":"6.40"},{"date":"2024-06-30","value":"21.30","vol":"11.96"},{"date":"2024-03-31","value":"14.63","vol":"1.49"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 8.77 | 12.05 | 25.51 | 21.30 | 14.63 |
| 行业 | 2.34 | 15.76 | 6.40 | 11.96 | 1.49 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"2.33","vol":"1.45"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"2.39","vol":"1.38"},{"date":"2024-03-31","value":"","vol":"0.00"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 2.33 | - | 2.39 | - |
| 行业 | 0.00 | 1.45 | 0.00 | 1.38 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 14/112 ， 26/112。
[{"date":"2025-03-31","value":"1.82","vol":"2.97"},{"date":"2024-12-31","value":"1.76","vol":"2.87"},{"date":"2024-09-30","value":"2.60","vol":"3.19"},{"date":"2024-06-30","value":"2.50","vol":"2.92"},{"date":"2024-03-31","value":"2.46","vol":"2.96"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
1.82 | 1.76 | 2.60 | 2.50 | 2.46 |
| 行业 | 2.97 | 2.87 | 3.19 | 2.92 | 2.96 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"1.50","vol":"2.19"},{"date":"2024-12-31","value":"1.44","vol":"2.09"},{"date":"2024-09-30","value":"2.18","vol":"2.38"},{"date":"2024-06-30","value":"2.10","vol":"2.20"},{"date":"2024-03-31","value":"2.18","vol":"2.26"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
1.50 | 1.44 | 2.18 | 2.10 | 2.18 |
| 行业 | 2.19 | 2.09 | 2.38 | 2.20 | 2.26 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 26/112 ， 30/112。
[{"date":"2025-03-31","value":"30.42","vol":"33.51"},{"date":"2024-12-31","value":"31.88","vol":"34.19"},{"date":"2024-09-30","value":"22.70","vol":"33.21"},{"date":"2024-06-30","value":"24.36","vol":"34.04"},{"date":"2024-03-31","value":"25.35","vol":"33.28"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
30.42 | 31.88 | 22.70 | 24.36 | 25.35 |
| 行业(%) | 33.51 | 34.19 | 33.21 | 34.04 | 33.28 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"0.46","vol":"0.73"},{"date":"2024-12-31","value":"0.49","vol":"0.75"},{"date":"2024-09-30","value":"0.30","vol":"3.21"},{"date":"2024-06-30","value":"0.33","vol":"1.65"},{"date":"2024-03-31","value":"0.35","vol":"0.98"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.46 | 0.49 | 0.30 | 0.33 | 0.35 |
| 行业(%) | 0.73 | 0.75 | 3.21 | 1.65 | 0.98 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 华泰证券 | 2025-06-30 | 买入 | |
| 华泰金融(HK) | 2025-06-30 | 买入 | |
| 招商证券 | 2025-06-12 | 买入 | |
| 国联民生 | 2025-05-15 | 买入 | 买入 |
| 中信证券 | 2025-05-07 | 买入 | |
| 西部证券 | 2025-04-10 | 增持 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"3.21","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"4.34","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"4.64","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"3.92","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"4.55","blueLineValue":"0.80","type":"YC"}]